Early results and volumetric analysis after spot-scanning proton therapy with concomitant hyperthermia in large inoperable sacral chordomas.

Tran, Sebastien; Puric, Emsad; Walser, Marc; Poel, Robert; Datta, Niloy Ranjan; Heuberger, Juerg; Pica, Alessia; Marder, Dietmar; Lomax, Nicoletta; Bolsi, Alessandra; Morach, Petra; Bachtiary, Barbara; Seddon, Beatrice M; Schneider, Ralf; Bodis, Stephan; Weber, Damien Charles (2020). Early results and volumetric analysis after spot-scanning proton therapy with concomitant hyperthermia in large inoperable sacral chordomas. The British journal of radiology, 93(1107), p. 20180883. British Institute of Radiology 10.1259/bjr.20180883

[img] Text
bjr.20180883.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

OBJECTIVE Large inoperable sacral chordomas show unsatisfactory local control rates even when treated with high dose proton therapy (PT). The aim of this study is assessing feasibility and reporting early results of patients treated with PT and concomitant hyperthermia (HT). METHODS:  Patients had histologically proven unresectable sacral chordomas and received 70 Gy (relative biological effectiveness) in 2.5 Gy fractions with concomitant weekly HT. Toxicity was assessed according to CTCAE_v4. A volumetric tumor response analysis was performed. RESULTS:  Five patients were treated with the combined approach. Median baseline tumor volume was 735 cc (range, 369-1142). All patients completed PT and received a median of 5 HT sessions (range, 2-6). Median follow-up was 18 months (range, 9-26). The volumetric analysis showed an objective response of all tumors (median shrinkage 46%; range, 9-72). All patients experienced acute Grade 2-3 local pain. One patient presented with a late Grade 3 iliac fracture. CONCLUSION Combining PT and HT in large inoperable sacral chordomas is feasible and causes acceptable toxicity. Volumetric analysis shows promising early results, warranting confirmation in the framework of a prospective trial. ADVANCES IN KNOWLEDGE:  This is an encouraging first report of the feasibility and early results of concomitant HT and PT in treating inoperable sacral chordoma.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Weber, Damien Charles

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1748-880X

Publisher:

British Institute of Radiology

Language:

English

Submitter:

Beatrice Scheidegger

Date Deposited:

24 Jul 2019 12:58

Last Modified:

23 Feb 2020 01:30

Publisher DOI:

10.1259/bjr.20180883

PubMed ID:

30943055

BORIS DOI:

10.7892/boris.131349

URI:

https://boris.unibe.ch/id/eprint/131349

Actions (login required)

Edit item Edit item
Provide Feedback